Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-17

Clinical Trial Update: Phase I/II Thymus Transplantation With Immunosuppression #950 [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II thymus transplantation with immunosuppression completed for DiGeorge anomaly, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thymus transplantation with immunosuppression

Snippet

Sponsor: Sumitomo Pharma Switzerland GmbH | Conditions: DiGeorge Anomaly, Complete DiGeorge Anomaly | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-17